Advances on relationship between phthalate exposure and perinatal depression
10.11836/JEOM24197
- VernacularTitle:邻苯二甲酸酯暴露与围产期抑郁发生风险关系的研究进展
- Author:
Yueming XU
1
;
Mei ZHAO
1
;
Yichao HUANG
1
;
Lingling YU
1
;
Lan GENG
1
;
Lei CHEN
1
Author Information
1. .
- Publication Type:Review
- Keywords:
phthalic acid esters;
maternal;
perinatal depression;
exposure;
biological mechanism
- From:
Journal of Environmental and Occupational Medicine
2024;41(12):1446-1451
- CountryChina
- Language:Chinese
-
Abstract:
Perinatal depression is a psychological disorder that occurs during pregnancy and within one year of delivery, which can seriously affect the physical and mental health of pregnant and postpartum women, as well as the cognitive and behavioral abilities of offspring, with potential multigenerational effects. Therefore, it is important to identify its potential modifiable risk factors. Phthalic acid esters (PAEs), as common environmental endocrine disruptors, can affect maternal estrogen through multiple mechanisms and are important potential modifiable risk factors for developing maternal perinatal depression. At present, studies on the correlation between PAEs and perinatal depression are still very limited, and the mechanisms by which PAEs affect perinatal depression have not been clarified. Based on existing epidemiological and toxicological studies at home and abroad, the article briefly introduced the characteristics of multiple pathways, high doses, and long-term exposure to maternal PAEs, focused on reviewing the current status of epidemiological studies, pointed out the possible associations between some specific PAEs exposure and elevated risk of perinatal depression. It also summarized the potential roles of hormone-neurotransmitter pathway, inflammation mediation, gene regulation, and other possible mechanisms in the association between exposure to PAEs and perinatal depression. The article concluded with a look at how future research on the association between exposure to PAEs and perinatal depression can be scientifically validated, with a view to providing more high-quality evidence for the scientific prevention of the onset and progression of maternal depressive symptoms.
